DR. BARRIE HERMAN LEVITT, M.D.
Osteopathic Medicine at Stonewall Ln, Mamaroneck, NY
License number
New York 60-084230
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
16 Stonewall Ln, Mamaroneck, NY 10543
Phone
(914) 381-2819
(914) 381-7644 (Fax)
(914) 381-7644 (Fax)
Professional information
Dr. Barrie H Levitt, Mamaroneck NY - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
16 Stonewall Ln, Mamaroneck 10543
(914) 381-2819 (Phone), (914) 381-7644 (Fax)
(914) 381-2819 (Phone), (914) 381-7644 (Fax)
Languages:
English
Education:
Medical School
Suny Downstate Medical Center
Graduated: 1959
Suny Downstate Medical Center
Graduated: 1959
Non-Sedating Barbiturate Compounds As Neuroprotective Agents
US Patent:
6756379, Jun 29, 2004
Filed:
Jan 27, 2003
Appl. No.:
10/333957
Inventors:
Daniel A. Moros - Larchmont NY
Barrie Levitt - Mamaroneck NY
Avraham Yacobi - Englewood NJ
Barrie Levitt - Mamaroneck NY
Avraham Yacobi - Englewood NJ
Assignee:
Taro Pharmaceutical Industries Ltd. - Haifa Bay
International Classification:
A61K 31515
US Classification:
514270
Abstract:
Methods of providing neuroprotection are disclosed comprising administering a non-sedative barbiturate compound in an amount sufficient to achieve neuroprotection in a mammalian subject. Preferred compounds are in the family of diphenylbarbituric acid and analogs. Preferred doses for a neuroprotective effect exceed the dosage of a corresponding sedative barbiturate without sedative side-effects such as anesthesia and death.
Process For Preparing Non-Hygroscopic Sodium Valproate Composition
US Patent:
6752997, Jun 22, 2004
Filed:
Jan 24, 2002
Appl. No.:
10/057155
Inventors:
Mohammed S. Safadi - Nazareth, IL
Maya Barder - Haifa, IL
Yechiel Golander - Haifa, IL
Avraham Yacobi - Englewood NJ
Daniel A. Moros - Larchmont NY
Barrie Levitt - Mamaroneck NY
Michael Friedman - Jerusalem, IL
Maya Barder - Haifa, IL
Yechiel Golander - Haifa, IL
Avraham Yacobi - Englewood NJ
Daniel A. Moros - Larchmont NY
Barrie Levitt - Mamaroneck NY
Michael Friedman - Jerusalem, IL
Assignee:
Taro Pharmaceuticals U.S.A., Inc. - Hawthorne NY
International Classification:
A61K 900
US Classification:
424400, 424401, 424451, 424452, 424464
Abstract:
The invention is directed to non-hygroscopic oral pharmaceutical compositions of a salt of valproic acid, and processes for preparing the compositions. The non-hygroscopic pharmaceutical compositions are prepared by blending a hygroscopic salt of valproic acid, carbomer, and a non-hygroscopic additive.
Sustained Release Formulation Of Carbamazepine
US Patent:
6162466, Dec 19, 2000
Filed:
Apr 15, 1999
Appl. No.:
9/292609
Inventors:
Daniela Licht - Givat Shmuel, IL
Marina Zholkoysky - Bat Yam, IL
Roman Kaplan - Holon, IL
Michael Friedman - Jerusalem, IL
Abraham Yacobi - New City NY
Yechiel Golander - Herzlia, IL
Dan Moros - Larchmont NY
Barrie Levitt - Mamaroneck NY
Marina Zholkoysky - Bat Yam, IL
Roman Kaplan - Holon, IL
Michael Friedman - Jerusalem, IL
Abraham Yacobi - New City NY
Yechiel Golander - Herzlia, IL
Dan Moros - Larchmont NY
Barrie Levitt - Mamaroneck NY
Assignee:
Taro Pharmaceutical Industries Ltd. - Herzlia
International Classification:
A61K 926, A61K 932
US Classification:
424468
Abstract:
The present invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication, preferably a sustained release formulation, and most preferably a sustained release formulation where the active ingredient is carbamazepine. The product consists of carbamazepine particles coated with a single hydrophobic layer and is in a disintegrating tablet form.
Composition And Method For Improved Bioavailability And Enhanced Brain Delivery Of 5,5-Diphenyl Barbituric Acid
US Patent:
7683071, Mar 23, 2010
Filed:
Aug 10, 2005
Appl. No.:
11/201024
Inventors:
Daniella Gutman - Rishon Lezion, IL
Barrie Levitt - Mamaroneck NY, US
Daniel Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
Barrie Levitt - Mamaroneck NY, US
Daniel Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
Assignee:
Taro Pharmaceuticals Industries Ltd. - Haifa Bay
International Classification:
A61K 31/515, C07D 239/62, C07D 239/64
US Classification:
514270, 544305
Abstract:
The present invention relates to a composition and a method of delivering a barbituric acid derivative to the central nervous system of a mammal in need of treatment for neurological conditions. In particular, the present invention relates to a method of administering an oral dosage form of a sodium salt of 5,5-diphenyl barbituric acid to enhance the bioavailability of 5,5-diphenyl barbituric acid and brain delivery of same.
Process For Preparing Non-Hygroscopic Sodium Valproate Composition
US Patent:
2002014, Oct 3, 2002
Filed:
Jan 24, 2001
Appl. No.:
09/767853
Inventors:
Mohammed Safadi - Nazareth, IL
Maya Barder - Haifa, IL
Yechiel Golander - Haifa, IL
Avraham Yacobi - Englewood NJ, US
Daniel Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Michael Friedman - Jerusalem, IL
Maya Barder - Haifa, IL
Yechiel Golander - Haifa, IL
Avraham Yacobi - Englewood NJ, US
Daniel Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Michael Friedman - Jerusalem, IL
Assignee:
TARO PHARMACEUTICAL INDUCTRIES LTD.
International Classification:
A61K031/19
US Classification:
514/557000
Abstract:
The invention provides a process for preparing a non-hygroscopic, highly stable, oral pharmaceutical composition of a salt of valproic acid. The pharmaceutical composition is prepared by blending ingredients including a hygroscopic salt of valproic acid, carbomer, and a non-hygroscopic additive such as dibasic calcium phosphate. Such a composition forms non-hygroscopic, highly moisture stable solid dosage form.
Process For Preparing Non-Hygroscopic Sodium Valproate Composition
US Patent:
2004020, Oct 21, 2004
Filed:
May 11, 2004
Appl. No.:
10/843936
Inventors:
Mohammed Safadi - Nazareth, IL
Maya Barder - Haifa, IL
Yechiel Golander - Haifa, IL
Avraham Yacobi - Englewood NJ, US
Daniel Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Michael Friedman - Jerusalem, IL
Maya Barder - Haifa, IL
Yechiel Golander - Haifa, IL
Avraham Yacobi - Englewood NJ, US
Daniel Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Michael Friedman - Jerusalem, IL
Assignee:
Taro Pharmaceuticals U.S.A. Inc. - Hawthorne NY
International Classification:
A61K031/19, A61K009/20, A61K009/36
US Classification:
424/465000, 514/557000
Abstract:
The invention is directed to non-hygroscopic oral pharmaceutical compositions of a salt of valproic acid, and processes for preparing the compositions. The non-hygroscopic pharmaceutical compositions are prepared by blending a hygroscopic salt of valproic acid, carbomer, and a non-hygroscopic additive.
Non-Sedating Barbiturate Compounds As Neuroprotective Agents
US Patent:
2004022, Nov 11, 2004
Filed:
Jun 10, 2004
Appl. No.:
10/865428
Inventors:
Daniel Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Avraham Yacobi - Englewood NJ, US
Barrie Levitt - Mamaroneck NY, US
Avraham Yacobi - Englewood NJ, US
International Classification:
A61K031/535
US Classification:
514/228800, 514/229200
Abstract:
Methods of providing neuroprotection are disclosed comprising administering a non-sedative barbiturate compound in an amount sufficient to achieve neuroprotection in a mammalian subject. Preferred compounds are in the family of diphenylbarbituric acid and analogs. Preferred doses for a neuroprotective effect exceed the dosage of a corresponding sedative barbiturate without sedative side-effects such as anesthesia and death.
Non-Sedating Barbiturate Compounds As Neuroprotective Agents
US Patent:
8158639, Apr 17, 2012
Filed:
Apr 13, 2010
Appl. No.:
12/759264
Inventors:
Daniel A. Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Avraham Yacobi - Englewood NJ, US
Barrie Levitt - Mamaroneck NY, US
Avraham Yacobi - Englewood NJ, US
Assignee:
Taro Pharmaceutical Industries Ltd. - Haifa Bay
International Classification:
A61K 31/55, C07D 239/64
US Classification:
514270, 544305
Abstract:
Methods of providing neuroprotection are disclosed comprising administering a non-sedative barbiturate compound in an amount sufficient to achieve neuroprotection in a mammalian subject. Preferred compounds are in the family of diphenylbarbituric acid and analogs. Preferred doses for a neuroprotective effect exceed the dosage of a corresponding sedative barbiturate without sedative side-effects such as anesthesia and death.
2-Alkyl-3-Benzoylbenzofurans Useful For Treating Cardiac Arrhythmia
US Patent:
4975458, Dec 4, 1990
Filed:
Mar 13, 1989
Appl. No.:
7/322369
Inventors:
Barrie Levitt - Mamaroneck NY
Morris Stolar - Tel Aviv, IL
Ron Breiman - Tel Aviv, IL
Morris Stolar - Tel Aviv, IL
Ron Breiman - Tel Aviv, IL
Assignee:
Taro Pharmaceuticals Industries, Ltd. - Haifa Bay
Taro Vit Industries, Ltd. - Haifa Bay
Taro Vit Industries, Ltd. - Haifa Bay
International Classification:
A61K 3134, C07D30778
US Classification:
514469
Abstract:
New 2-alkyl-3-(4-hydroxy-3,5-di-tert-butylbenzoyl)benzofurans useful for treating cardiac arrhythmia, as well as pharmaceutical compositions containing these benzofurans and the method of treating cardiac arrhythmia therewith are disclosed.